Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca 
Welcome,         Profile    Billing    Logout  
 16 Diseases   2 Trials   2 Trials   50 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
ACTRN12622001217796: A Randomised Controlled Trial of the efficacy and safety of an Inhaled Corticosteroid and Long Acting Beta Agonist maintenance and/or reliever therapy versus standard maintenance with separate reliever therapy in children with mild, moderate and severe asthma.

Recruiting
3
400
 
Medical Research Institute of New Zealand, AstraZeneca Ltd
Asthma
 
 
ChiCTR-TRC-09000566: Mild Asthma--as-needed Symbicort Turbuhaler clinical study

Completed
3
450
 
one inhalation of Pulmicort Turbuhaler 200 ug/inhalation ;Oxis Turbuhaler 4.5 ug/inhalation with symptom-driving ;Symbicort Turbuhaler 160/4.5 ug/inhalation with symptom-driving
1st Affiliated Hospital of SYSU; 2nd and 3rd Affiliated Hospital of SYSU, 1st Affiliated Hospital of SYSU
mild asthma
 
 
2005-005469-12: A Phase III, randomised, double-blind, double-dummy cross-over study to compare two dry powder inhaled formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, moderate asthma.

Ongoing
3
30
Europe
Budesonide Test DPI, Pulmicort Turbohaler 200, Test DPI, Reference DPI, Pulmicort Turbohaler 200, Pulmicort Turbohaler 200
Neolab Limited
Stable, persistent, moderate asthma
 
 
ChiCTR-TRC-12002459: Therapeutic effect of inhaled budesonide (Pulmicort Turbuhaler) on lung inflammatory response to the one lung ventilation

Completed
N/A
60
 
nebulized saline ;nebulized budesonide
Department of ICU, The Affiliated Tumor Hospital, Harbin Medical University; Level of the institution：, NO
lung cancer
 
 

Download Options